Histone demethylase RBP2 is critical for breast cancer progression and metastasis

Cell Reports

Volumn 6, Issue 5, 2014, Pages 868-877

  Cao, Jian ^a   Liu, Zongzhi ^a   Cheung, William K C ^a   Zhao, Minghui ^a   Chen, Sophia Y ^a   Chan, SiewWee ^b   Booth, Carmen J ^a   Nguyen, Don X ^a   Yan, Qin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA BINDING PROTEIN 2; TENASCIN; CELLULAR RETINOL BINDING PROTEIN; HISTONE DEMETHYLASE; RBP2 PROTEIN, HUMAN; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE LYSINE DEMETHYLASE; HISTONE LYSINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CANCER GROWTH; CELL INVASION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TNC GENE; TRANSGENIC MOUSE; ANIMAL; BREAST TUMOR; DISEASE COURSE; ENZYMOLOGY; EXPERIMENTAL MAMMARY NEOPLASM; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSFECTION; GENETICS; METABOLISM; METASTASIS; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; TUMOR CELL LINE; ANIMAL CELL; CANCER INHIBITION; CORRELATIONAL STUDY; DOWN REGULATION; ENZYME ASSAY; ENZYME KINETICS; GENE CONTROL; GENE OVEREXPRESSION; GENE SILENCING; GENE SWITCHING; GENETIC ASSOCIATION; IN VIVO STUDY; PROTEIN DEPLETION; PROTEIN SYNTHESIS; RBP2 GENE; TUMOR INVASION;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEMETHYLASES; HUMANS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; NEOPLASM METASTASIS; RETINOL-BINDING PROTEINS, CELLULAR; TRANSFECTION;

EID: 84895921477     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.02.004     Document Type: Article

References (58)

1. Aslakson C.J., Miller F.R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992, 52:1399-1405.
2. Benevolenskaya E.V., Murray H.L., Branton P., Young R.A., Kaelin W.G. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell 2005, 18:623-635.
3. Beshiri M.L., Holmes K.B., Richter W.F., Hess S., Islam A.B., Yan Q., Plante L., Litovchick L., Gévry N., Lopez-Bigas N., et al. Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation. Proc. Natl. Acad. Sci. USA 2012, 109:18499-18504.
4. Blair L.P., Yan Q. Epigenetic mechanisms in commonly occurring cancers. DNA Cell Biol. 2012, 31(Suppl 1):S49-S61.
5. Blair L.P., Cao J., Zou M.R., Sayegh J., Yan Q. Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer. Cancers (Basel) 2011, 3:1383-1404.
6. Bos P.D., Zhang X.H., Nadal C., Shu W., Gomis R.R., Nguyen D.X., Minn A.J., van de Vijver M.J., Gerald W.L., Foekens J.A., Massagué J. Genes that mediate breast cancer metastasis to the brain. Nature 2009, 459:1005-1009.
7. Brabletz T. EMT and MET in metastasis: where are the cancer stem cells?. Cancer Cell 2012, 22:699-701.
8. Cao J., Yan Q. Histone demethylases set the stage for cancer metastasis. Sci. Signal. 2013, 6:pe15. 1-2.
9. Carey L., Winer E., Viale G., Cameron D., Gianni L. Triple-negative breast cancer: disease entity or title of convenience?. Nat. Rev. Clin. Oncol. 2010, 7:683-692.
10. Chan S.W., Hong W. Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription. J.Biol. Chem. 2001, 276:28402-28412.
11. Cheung W.K., Zhao M., Liu Z., Stevens L.E., Cao P.D., Fang J.E., Westbrook T.F., Nguyen D.X. Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis. Cancer Cell 2013, 23:725-738.
12. Christensen J., Agger K., Cloos P.A.C., Pasini D., Rose S., Sennels L., Rappsilber J., Hansen K.H., Salcini A.E., Helin K. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 2007, 128:1063-1076.
13. Defeo-Jones D., Huang P.S., Jones R.E., Haskell K.M., Vuocolo G.A., Hanobik M.G., Huber H.E., Oliff A. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 1991, 352:251-254.
14. DeSantis C., Siegel R., Bandi P., Jemal A. Breast cancer statistics, 2011. CA Cancer J. Clin. 2011, 61:409-418.
15. Guy C.T., Webster M.A., Schaller M., Parsons T.J., Cardiff R.D., Muller W.J. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 1992, 89:10578-10582.
16. Györffy B., Lanczky A., Eklund A.C., Denkert C., Budczies J., Li Q., Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 2010, 123:725-731.
17. Hancox R.A., Allen M.D., Holliday D.L., Edwards D.R., Pennington C.J., Guttery D.S., Shaw J.A., Walker R.A., Pringle J.H., Jones J.L. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res. 2009, 11:R24.
18. Hou J., Wu J., Dombkowski A., Zhang K., Holowatyj A., Boerner J.L., Yang Z.Q. Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer. Am. J. Transl. Res. 2012, 4:247-256.
19. Iwase S., Lan F., Bayliss P., de la Torre-Ubieta L., Huarte M., Qi H.H., Whetstine J.R., Bonni A., Roberts T.M., Shi Y. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 2007, 128:1077-1088.
20. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordón-Cardo C., Guise T.A., Massagué J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
21. Kim Y.W., Otterson G.A., Kratzke R.A., Coxon A.B., Kaye F.J. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein. Mol. Cell. Biol. 1994, 14:7256-7264.
22. Kleer C.G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S.A., Ghosh D., Sewalt R.G., Otte A.P., Hayes D.F., et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA 2003, 100:11606-11611.
23. Klose R.J., Yan Q., Tothova Z., Yamane K., Erdjument-Bromage H., Tempst P., Gilliland D.G., Zhang Y., Kaelin W.G. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 2007, 128:889-900.
24. Lee M.G., Norman J., Shilatifard A., Shiekhattar R. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 2007, 128:877-887.
25. Li L., Greer C., Eisenman R.N., Secombe J. Essential functions of the histone demethylase lid. PLoS Genet. 2010, 6:e1001221.
26. Lin W., Cao J., Liu J., Beshiri M.L., Fujiwara Y., Francis J., Cherniack A.D., Geisen C., Blair L.P., Zou M.R., et al. Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proc. Natl. Acad. Sci. USA 2011, 108:13379-13386.
27. Lu X., Mu E., Wei Y., Riethdorf S., Yang Q., Yuan M., Yan J., Hua Y., Tiede B.J., Lu X., et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell 2011, 20:701-714.
28. Luo W.B., Chang R., Zhong J., Pandey A., Semenza G.L. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proc. Natl. Acad. Sci. USA 2012, 109:E3367-E3376.
29. Min J., Zaslavsky A., Fedele G., McLaughlin S.K., Reczek E.E., De Raedt T., Guney I., Strochlic D.E., Macconaill L.E., Beroukhim R., et al. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat. Med. 2010, 16:286-294.
30. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massagué J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
31. Minn A.J., Gupta G.P., Padua D., Bos P., Nguyen D.X., Nuyten D., Kreike B., Zhang Y., Wang Y., Ishwaran H., et al. Lung metastasis genes couple breast tumor size and metastatic spread. Proc. Natl. Acad. Sci. USA 2007, 104:6740-6745.
32. Moore H.M., Gonzalez M.E., Toy K.A., Cimino-Mathews A., Argani P., Kleer C.G. EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis. Breast Cancer Res. Treat. 2013, 138:741-752.
33. Nagaharu K., Zhang X., Yoshida T., Katoh D., Hanamura N., Kozuka Y., Ogawa T., Shiraishi T., Imanaka-Yoshida K. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am. J. Pathol. 2011, 178:754-763.
34. Nguyen D.X., Massagué J. Genetic determinants of cancer metastasis. Nat. Rev. Genet. 2007, 8:341-352.
35. Nguyen D.X., Bos P.D., Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9:274-284.
36. Nguyen D.X., Chiang A.C., Zhang X.H.F., Kim J.Y., Kris M.G., Ladanyi M., Gerald W.L., Massagué J. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009, 138:51-62.
37. Oskarsson T., Acharyya S., Zhang X.H., Vanharanta S., Tavazoie S.F., Morris P.G., Downey R.J., Manova-Todorova K., Brogi E., Massagué J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 2011, 17:867-874.
38. Paolicchi E., Crea F., Farrar W.L., Green J.E., Danesi R. Histone lysine demethylases in breast cancer. Crit. Rev. Oncol. Hematol. 2013, 86:97-103.
39. Peinado H., Alečković M., Lavotshkin S., Matei I., Costa-Silva B., Moreno-Bueno G., Hergueta-Redondo M., Williams C., García-Santos G., Ghajar C., et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 2012, 18:883-891.
40. Ringnér M., Fredlund E., Häkkinen J., Borg A., Staaf J. GOBO: gene expression-based outcome for breast cancer online. PLoS ONE 2011, 6:e17911.
41. Rodríguez-Paredes M., Esteller M. Cancer epigenetics reaches mainstream oncology. Nat. Med. 2011, 17:330-339.
42. Sayegh J., Cao J., Zou M.R., Morales A., Blair L.P., Norcia M., Hoyer D., Tackett A.J., Merkel J.S., Yan Q. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen. J.Biol. Chem. 2013, 288:9408-9417.
43. Secombe J., Li L., Carlos L., Eisenman R.N. The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev. 2007, 21:537-551.
44. Sethi N., Kang Y. Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nat. Rev. Cancer 2011, 11:735-748.
45. Sharma S.V., Lee D.Y., Li B., Quinlan M.P., Takahashi F., Maheswaran S., McDermott U., Azizian N., Zou L., Fischbach M.A., et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010, 141:69-80.
46. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
47. Tahiliani M., Mei P., Fang R., Leonor T., Rutenberg M., Shimizu F., Li J., Rao A., Shi Y. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 2007, 447:601-605.
48. Tavazoie S.F., Alarcón C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152.
49. Teng Y.C., Lee C.F., Li Y.S., Chen Y.R., Hsiao P.W., Chan M.Y., Lin F.M., Huang H.D., Chen Y.T., Jeng Y.M., et al. Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res. 2013, 73:4711-4721.
50. Tiwari N., Tiwari V.K., Waldmeier L., Balwierz P.J., Arnold P., Pachkov M., Meyer-Schaller N., Schübeler D., van Nimwegen E., Christofori G. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell 2013, 23:768-783.
51. Tu S., Teng Y.C., Yuan C., Wu Y.T., Chan M.Y., Cheng A.N., Lin P.H., Juan L.J., Tsai M.D. The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif. Nat. Struct. Mol. Biol. 2008, 15:419-421.
52. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002, 419:624-629.
53. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., Talantov D., Timmermans M., Meijer-van Gelder M.E., Yu J., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
54. Wang G.G., Song J., Wang Z., Dormann H.L., Casadio F., Li H., Luo J.L., Patel D.J., Allis C.D. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009, 459:847-851.
55. Wang Y., Zhang H., Chen Y.P., Sun Y.M., Yang F., Yu W.H., Liang J., Sun L.Y., Yang X.H., Shi L., et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009, 138:660-672.
56. Yamane K., Tateishi K., Klose R.J., Fang J., Fabrizio L.A., Erdjument-Bromage H., Taylor-Papadimitriou J., Tempst P., Zhang Y. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell 2007, 25:801-812.
57. Yang H., Minamishima Y.A., Yan Q., Schlisio S., Ebert B.L., Zhang X., Zhang L., Kim W.Y., Olumi A.F., Kaelin W.G. pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol. Cell 2007, 28:15-27.
58. Zeng J.P., Ge Z., Wang L.X., Li Q., Wang N., Björkholm M., Jia J.H., Xu D.W. The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology 2010, 138:981-992.